Moxibustion influences hippocampal microglia polarization via IL-33/ST2 pathway in Alzheimer's disease mice

Hong-Ying Li1, Yuan Shen2, Lu-Shuang Xie3

  • 1Acupuncture-moxibustion and Tuina College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China. 1558494627@qq.com.

Abstract

Insights

Moxibustion improved spatial memory in Alzheimer's disease (AD) mice by enhancing the interleukin-33 (IL-33)/ST2 pathway, promoting M2 microglia polarization, and reducing amyloid-beta (Aβ) and phosphorylated Tau (p-Tau) pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Traditional Chinese Medicine

Background:

  • Alzheimer's disease (AD) is characterized by neuroinflammation and the accumulation of amyloid-beta (Aβ) and phosphorylated Tau (p-Tau).
  • Microglia polarization plays a crucial role in AD pathogenesis, with M2 polarization generally considered neuroprotective.
  • The interleukin-33 (IL-33)/ST2 signaling pathway is implicated in regulating microglial polarization.

Purpose of the Study:

  • To investigate the effect of moxibustion on M2 microglia polarization in AD mice.
  • To explore the role of the IL-33/ST2 signaling pathway in mediating moxibustion's effects on AD.

Main Methods:

  • APP/PS1 mice were treated with moxibustion at specific acupoints (GV20, KI1) for 4 weeks.
  • Spatial learning and memory were assessed using the Morris water maze test.
  • Hippocampal expression of IL-33, ST2, Aβ, p-Tau, and microglial markers (Iba-1) was analyzed via Western blot and immunofluorescence.

Main Results:

  • Moxibustion significantly improved spatial learning and memory in AD mice.
  • Treatment reduced Aβ and p-Tau deposition and decreased iNOS/Iba-1 expression (M1 microglia marker).
  • Moxibustion increased IL-33 and ST2 protein expression, along with IL-33/Iba-1, ST2/Iba-1, and Arg1/Iba-1 (M2 microglia marker) levels.

Conclusions:

  • Moxibustion ameliorates cognitive deficits and neuropathology in AD mice.
  • The therapeutic effects are associated with the upregulation of the IL-33/ST2 pathway.
  • This pathway modulation promotes M2 microglia polarization, suggesting a novel therapeutic strategy for AD.

Related Concept Videos